Clarity wanted: When can new drug price negotiations be challenged in court?

The inevitable lawsuit over the incoming rules around how the CMS plans to negotiate some of the most expensive drug prices has the Congressional Research Service already calling on Congress to be more clear about the types of legal challenges it intends to prohibit under the new law. Gilead recently…